previous compound ID: 2045 next compound
InChIKey: RZEKVGVHFLEQIL-UHFFFAOYSA-N
SMILES: CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "SD Macknight" "GW Carlile" "R Robert" "E Matthes" "JW Hanrahan" "D Rotin" "B Kus" "J Goepp" "DY Thomas"

chemical graph of compound 2045





CID is 2662
synonyms found at PubChem are:
celecoxib, Celebrex, 169590-42-5, Celebra, Onsenal, Celocoxib, Celecox, SC 58635, Xilebao, YM177, SC-58635, 4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE, Celecoxib [USAN], Celecoxib [Old RN], YM 177, Celecoxibum, Celecoxi, Solexa, 184007-95-2, HSDB 7038, UNII-JCX84Q7J1L, Celebrex (TN), C17H14F3N3O2S, p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide, 4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide, YM-177, CHEMBL118, SC58635, JCX84Q7J1L, Celecoxib (SC-58635), Celecoxib (JAN/USAN/INN), 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide, CHEBI:41423, TPI-336, RZEKVGVHFLEQIL-UHFFFAOYSA-N, AI-525, CEP-33222, NCGC00091455-01, DSSTox_CID_2777, SC-58553, SC-58635, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide, benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-, DSSTox_RID_76725, DSSTox_GSID_22777, 194044-54-7, 4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide, 4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide, Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-, Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl), SMR000550473, CAS-169590-42-5, SR-01000837528, Eurocox, Medicoxib, Celecoxib [USAN:INN:BAN], CCRIS 8679, CCRIS 9330, Celebra (TN), Onsenal (TN), CELEBCOXIB, Spectrum_000432, 1oq5, Pfizer brand of celecoxib, Spectrum2_001576, Spectrum3_001996, Spectrum4_000182, Spectrum5_001324, D03RTS, AC1L1E6K, Celecoxib/Celebrex, Celebra, cid_2662, SCHEMBL3708, BSPBio_003596, Celebrex, Celebra, Celecoxib, KBioGR_000723, KBioGR_002351, KBioSS_000912, KBioSS_002354, MLS001165684, MLS001195656, MLS001304708, MLS006011862, BIDD:GT0408, DivK1c_000893, SPECTRUM1503678, SPBio_001512, GTPL2892, Celecoxib, >=98% (HPLC), DTXSID0022777, BDBM11639, CTK8H4475, HMS502M15, KBio1_000893, KBio2_000912, KBio2_002351, KBio2_003480, KBio2_004919, KBio2_006048, KBio2_007487, KBio3_002830, KBio3_003037, EX-A175, SYN3015, cMAP_000027, MolPort-002-885-815, NINDS_000893, BCPP000290, HMS1922G14, HMS2089L18, HMS2093I07, HMS2234N18, HMS3259L08, HMS3261A14, HMS3373A09, HMS3654H09, HMS3715F11, Pharmakon1600-01503678, ACT02648, BCP02156, EBD24636, KS-00000FW2, ZINC2570895, Tox21_111135, Tox21_201964, Tox21_300599, Tox21_500406, US8741944, Comparative Compound, ABP000291, BBL029086, CCG-39354, MFCD00941298, NSC719627, NSC758624, s1261, STL373576, Celecoxib 1.0 mg/ml in Acetonitrile, AKOS015842517, Tox21_111135_1, AC-4228, AM84588, AT-3762, BCP9000507, Celebrex, Celebra, 169590-42-5, CS-0570, DB00482, KS-1041, MCULE-4750749400, NC00708, NSC-719627, NSC-758624, RL02184, IDI1_000893, NCGC00091455-02, NCGC00091455-03, NCGC00091455-04, NCGC00091455-05, NCGC00091455-06, NCGC00091455-07, NCGC00091455-08, NCGC00091455-09, NCGC00091455-13, NCGC00254540-01, NCGC00259513-01, NCGC00261091-01, AN-12211, BC209720, BP-30217, CPD000550473, HY-14398, KB-76000, LS-31667, NCI60_041049, PHA-00846533, SAM002589995, SC-50829, SBI-0051875.P002, AB0012055, CJ-016377, CP-598107, TL8001323, UNM-0000305813, FT-0080064, FT-0601628, FT-0623536, FT-0700357, PF-00345549, A25046, C-6317, C07589, D00567, J10035, AB00052396-07, AB00052396-08, AB00052396-09, AB00052396_10, AB00052396_11, Celecoxib|169590-42-5|Celebrex|SC 58635, 590C425, I01-1033, J-010566, J-520011, Q-200816, SR-01000837528-2, SR-01000837528-3, BRD-K02637541-001-02-4, BRD-K02637541-001-06-5, Z2210694606, Celecoxib, European Pharmacopoeia (EP) Reference Standard, Celecoxib, United States Pharmacopeia (USP) Reference Standard, 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide, 5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole, Celecoxib, Pharmaceutical Secondary Standard; Certified Reference Material, Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-